Diagnostic Capability and Improved Clinical Management of 18F-DCFPyL-PSMA PET/CT in Occult Biochemical Recurrence of Prostate Cancer After Prostatectomy
18F-DCFPyL PET/CT demonstrates high sensitivity for detecting recurrent PC at low PSA levels, significantly impacting therapeutic decisions and optimizing clinical management. These findings support its integration into guidelines for managing early BCR of PC.
Authors
- Pedro Plaza
- Abrahams Ocanto (ORCID: https://orcid.org/0000-0002-6494-8197)
- P. Foro (ORCID: https://orcid.org/0000-0001-8578-3777)
- Lluís Fumadó (ORCID: https://orcid.org/0000-0003-3996-167X)
- Andrea Natali (ORCID: https://orcid.org/0000-0002-8465-7717)
- Francesco Amorelli
- Juan José Ríos Blanco (ORCID: https://orcid.org/0000-0001-5257-6042)
Institutions
- Universitat Pompeu Fabra (ES)
- Hospital Del Mar (ES)
- Hospital Universitari de Girona Doctor Josep Trueta (ES)
Publication Details
- Journal
- Cancers
- Published
- 2025-04-09
- DOI
- https://doi.org/10.3390/cancers17081272
- Citations
- 3
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 4.56